Harrow Health Inc logo

Harrow Health Inc

$ 11.52 +1.61 (+16.25%) 08:08 PM EST
On watch
P/E:
At Loss
P/B:
56.69
Market Cap:
$ 311.85M
Enterprise V:
$ 297.01M
Volume:
675.76K
Avg Vol (2M):
132.02K
Also Trade In:
Volume:
675.76K
Market Cap $:
311.85M
PE Ratio:
At Loss
Avg Vol (2-Month):
132.02K
Enterprise Value $:
297.01M
PB Ratio:
56.69
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Harrow Health Inc is an ophthalmology-focused pharmaceutical company. The company is specialized in the development, production, and sale of medications that offer competitive advantages and serve unmet needs in the marketplace. Its cornerstone of ophthalmology program consists of proprietary Dropless Therapy injectable and LessDrops topical formulations that are designed to address patient compliance issues and provide other compelling medical and economic benefits.
Name Current Vs Industry Vs History
Cash-To-Debt 0.64
Equity-to-Asset 0.06
Debt-to-Equity 13.98
Debt-to-EBITDA 271.55
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.17
Distress
Grey
Safe
Beneish M-Score -0.22
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 86.65
9-Day RSI 79.58
14-Day RSI 75.17
6-1 Month Momentum % 24.47
12-1 Month Momentum % -3.53

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.01
Quick Ratio 4.61
Cash Ratio 4
Days Inventory 69.92
Days Sales Outstanding 33.52
Days Payable 88.67

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.4

Financials (Next Earnings Date:2022-11-09 Est.)

HROW's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:HROW

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 84.342
EPS (TTM) ($) -0.9
Beta 1.21
Volatility % 47.5
14-Day RSI 75.17
14-Day ATR ($) 0.741906
20-Day SMA ($) 8.981
12-1 Month Momentum % -3.53
52-Week Range ($) 5.4 - 12.99
Shares Outstanding (Mil) 27.07

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Harrow Health Inc Filings

Document Form Filing Date
No Filing Data

Harrow Health Inc Analysis

Share your research

Headlines

See More
No news.